 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
Esophageal Cancer
| Bryostatin-1 (bryostatin) |
Protein kinase activator |
GPC Biotech |
II |
| Gastrimmune, G17DT (antigastrin) |
Vaccine |
Aventis Pasteur |
II |
| Lucent protein |
Targeted drug delivery |
Biomedics |
II |
| Taxotere (docetaxel) |
Taxoid |
Aventis |
II |
| T607 (T138067) |
Tubulin antagonist |
Amgen |
II |
| TNFerade |
Tumor necrosis factor alpha gene |
GenVec |
II |
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
 View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|
Patient Home
Meeting Calendar
